As of 2022, in nearly every country in Europe, over half of adults were classed as overweight or obese. The highest rate was recorded in Romania with 67 percent of adults self-reporting as overweight or obese. In both Croatia and the United Kingdom, around 64 percent of adults had a BMI of over 25. Europe one of the worst affected regions Europe had the second-highest number of obese adults across the WHO regions, only behind the region of the Americas. Over 191 million adults aged 20 years were classed as obese in Europe in 2020. The number of obese adults in Europe was forecast to grow to 263 million by 2035. Problems also with childhood obesity In 2020, 89 million children in Europe were overweight, the highest across all continents. It was forecast with current trends that, by 2035, 125 million children would be overweight. A further 70 million children across the continent were classed as obese. Children that are overweight or obese are at a higher risk of developing numerous health conditions, such as type 2 diabetes, asthma, and high blood pressure.

As of 2021, approximately 69 percent of men and 59 percent of women in the United Kingdom considered themselves overweight or obese. Across the European countries featured, overweight and obesity was more prevalent among males.

By 2025, the prevalence of obese men in Hungary was projected to be at 36 percent, this would be the highest obesity prevalence in men across all countries in the EU and the United Kingdom. Malta with 35.9 percent was forecast to have the second highest prevalence of obese men in Europe, followed by the United Kingdom at 35.4 percent.

This statistic displays the obesity prevalence in selected European countries by 2025. Great Britain is set to be the most obese nation in Europe by 2025 with an obesity prevalence of 37.7 percent, followed closely by Ireland and Lithuania with an expected prevalence rate of 37.65 percent respectively.

By 2025, the prevalence of obese women in the United Kingdom is projected to be at 36 percent, this would be the highest obesity prevalence in women compared to EU countries. Ireland with 33.4 percent was forecast to have the second highest prevalence of obese women in Europe, followed by Malta at 32 percent.

By 2030, Malta, Hungary, and the United Kingdom were projected to have the highest prevalence of obesity in their populations among men in Europe. Across the whole of Europe, approximately 30 percent of men were forecast to be classified as obese in 2030.

By 2025, the prevalence of obese children in Greece is projected to reach 16.7 percent, this would be the highest childhood obesity prevalence across all countries in the EU and the UK. Hungary with 16.2 percent was forecast to have the second highest prevalence of childhood obesity in Europe, followed by Croatia at 15.9 percent.

The indicator measures the share of obese people based on their body mass index (BMI). BMI is defined as the weight in kilos divided by the square of the height in meters. People aged 18 years or over are considered obese with a BMI equal or greater than 30. Other categories are: underweight (BMI less than 18.5), normal weight (BMI between 18.5 and less than 25), and pre-obese (BMI between 25 and less than 30). The category overweight (BMI equal or greater than 25) combines the two categories pre-obese and obese. Copyright notice and free re-use of data on: https://ec.europa.eu/eurostat/about-us/policies/copyright

This statistic displays the prevalence of obesity among 15 to 19 year olds in selected European countries in 2016. In this year, the United Kingdom had the highest share of obesity in this age group at 8.1 percent, while in Italy only 3.8 percent of those aged 15 to 19 years were classed as obese.

Snapshot img

Weight Management Market Size 2024-2028

The weight management market size is forecast to increase by USD 103.8 billion at a CAGR of 10.87% between 2023 and 2028.

The market is witnessing significant growth due to rising obesity rates, particularly in developed and developing economies. The increasing prevalence of sedentary lifestyles, coupled with the influence of social media platforms promoting unhealthy food choices, is fueling this trend. The fast-food industry's continuous expansion and the availability of convenient yet calorie-dense options further exacerbate the issue. Key health concerns, such as cardiovascular diseases, diabetes, hormonal problems, and certain cancers, are associated with obesity. As a result, consumers are seeking effective solutions, leading to a rise in demand for diet meals, beverages, and supplements. This trend is expected to continue, as chronic diseases linked to obesity pose a significant threat to public health. The market is also witnessing innovative marketing strategies and personalized approaches to cater to the diverse needs of consumers. Despite these opportunities, challenges remain, including regulatory hurdles and consumer skepticism towards weight loss solutions.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses a range of products and services aimed at helping individuals maintain a healthy body weight and improve overall wellness. Obesity, driven by sedentary lifestyles and unhealthy dietary choices, remains a significant global health concern, fueling market growth. Chronic diseases, such as diabetes, hypertension, orthopedic diseases, and cardiovascular diseases, are often associated with obesity and create a strong demand for solutions. 
Additionally, hormonal problems and childhood obesity contribute to market expansion. Preventive health measures, including healthy eating habits, daily physical activities, and services, are increasingly popular. Social media plays a role in promoting weight loss trends, from bariatric surgeries to protein powders and fitness programs. The young population and the Gen X and baby boomer generations are key demographics, as they seek to maintain a healthy weight and address age-related health concerns.

How is this Weight Management Industry segmented and which is the largest segment?

The report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Diet
  Equipment
  Services


Distribution Channel

  Offline
  Online


Geography

  North America

    US


  Asia

    China
    Japan


  Europe

    Germany
    UK


  Rest of World (ROW)

By Type Insights

The diet segment is estimated to witness significant growth during the forecast period.

The market is driven by the increasing prevalence of obesity and related health conditions, including hypertension, diabetes, and orthopedic diseases. Sedentary lifestyles and the consumption of junk food and fast-food contribute to obesity, affecting over one-third of the global population. Obesity can lead to chronic diseases, such as cardiovascular diseases and certain types of cancer. The market includes various segments, such as diet meals, beverages and supplements, exercise, surgical procedures, and services. Digitalization has led to the growth of online sales, ready-to-drink beverages, bars, gels, and powders. Lifestyle changes, including healthy eating habits and daily physical activities, are essential for maintaining a healthy body weight.

Weight management programs and innovative weight-management products, such as functional beverages, functional food, and dietary supplements, offer prevention and consultation services. The market is expected to grow due to the increasing awareness of weight-related health issues and the desire for a healthy immune system among the young population and Gen X and baby boomer generations.

Get a glance at the market report of the share of various segments Request Free Sample

The diet segment was valued at USD 84.90 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 36% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The market in North America is currently the largest global segment, driven by increasing consumer focus on healthier lifestyles and obesity concerns. With over 35% of American adults classified as obese in 2022, according to the Centers for Disease Control and Prevention (CDC), the US market dominates th

Snapshot img

Anti-Obesity Drugs Market Size 2025-2029

The anti-obesity drugs market size is forecast to increase by USD 22.91 billion at a CAGR of 15.7% between 2024 and 2029.

The market is experiencing significant growth due to several key factors. The rising obesity population, particularly in North America, is a major driver for this market. Additionally, research and development efforts are focused on creating drugs that can effectively manage both obesity and type 2 diabetes mellitus. This dual-action approach is gaining popularity as many obese individuals are also at risk for developing type 2 diabetes. Furthermore, the availability of telemedicine services and anti-obesity devices is making weight management more accessible and convenient for individuals. These trends are expected to continue fueling the growth of the market In the coming years. The use of anti-obesity drugs can help regulate insulin production and manage weight by reducing appetite and increasing metabolism. These drugs can have a positive impact on overall health and well-being, making them an essential tool In the fight against obesity and related health conditions.

What will be the Size of the Anti-Obesity Drugs Market During the Forecast Period?

Request Free Sample

The market encompasses a range of medicines designed to assist individuals struggling with weight management, targeting conditions such as obesity and overweight. These conditions are often linked to chronic diseases, including insulin resistance, glucose intolerance, hypertension, sleep apnea, diabetes mellitus, arthritis, and various lifestyle-related illnesses. The prevalence of obesity and overweight continues to rise globally, driven by energy imbalance, with calories consumed exceeding calories expended. Factors contributing to this imbalance include appetite stimulation, metabolic disorders, and fat absorption. The market for anti-obesity drugs is expected to grow significantly due to the increasing burden of obesity and its associated health complications.
This trend is driven by the growing awareness of the health risks associated with obesity and the desire for effective weight loss solutions. The market caters to both adults and children and adolescents, addressing the rising prevalence of obesity across all age groups. The market's growth is further fueled by the increasing incidence of lifestyle-related factors, such as stress, smoking, and drinking, which contribute to weight gain.

How is this Anti-Obesity Drugs Industry segmented and which is the largest segment?

The anti-obesity drugs industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Class III
  Class II anti-obesity drugs
  Class I anti-obesity drugs


Drug Class

  Peripherally acting drugs
  Centrally acting drugs


Distribution Channel

  Hospital pharmacies
  Retail pharmacies
  Drug stores
  E-commerce


Route Of Administration

  Oral route
  Subcutaneous route


Geography

  North America

    Canada
    Mexico
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    Japan


  Rest of World (ROW)

By Type Insights

The class III segment is estimated to witness significant growth during the forecast period. The Class III segment dominates The market due to its focus on addressing severe obesity cases. This segment accounts for a significant market share and is expected to continue its leadership during the forecast period. The rise in research and development initiatives by pharmaceutical companies for novel anti-obesity drugs contributes to market expansion. However, it's important to note that pharmacotherapy for obesity can only achieve a certain reduction in Body Mass Index (BMI). Consequently, the Class III anti-obesity drugs segment may witness a decline during the forecast period as patients may require additional measures for sustained weight loss.
Obesity is a chronic condition with a global prevalence that fuels the demand for weight-loss medicines. These medicines target various mechanisms such as appetite suppression, metabolism enhancement, and fat absorption inhibition. Prevalent conditions associated with obesity include cardiovascular diseases, cancers, type-2 diabetes, and sleep apnea. The market caters to various distribution channels, including retail pharmacies, online pharmacies, and hospital pharmacies. Anti-obesity drugs can be administered through oral and subcutaneous routes.

Get a glance at the market report of share of various segments Request Free Sample

The class III segment was valued at USD 6.85 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 71% to the growth o

As of 2022, over 42 percent of the population in Greece self-reported themselves as overweight. Furthermore, around 39 percent in Czechia were classed as overweight. Across the European countries featured, the majority had more than a third of their population classed as overweight.

ID = identification number, WC = waist circumference, MAF = minor allele frequency, HWE = Hardy Weinberg equilibrium, SE = Standard error, N = Number of individuals.ap-value of exact HWE test.bResults of multiple linear regression analyses adjusted for sex, age, education, occupational activity, smoking, and alcohol, energy, fat, fruit and vegetable intake. SNPs were included in the models coded as 0, 1, 2 for minor allele count.

There is evidence that replacing saturated fat (SFA) with polyunsaturated fat (PUFA) lowers ischemic heart disease (IHD). In order to improve the population’s diet, the World Health Organization has called for the taxation of foods that are high in SFA. We aimed to assess the potential health gains of a European fat tax by applying the SFA intake reduction that has been observed under the Danish fat tax to six other European countries. For each country, we created a fat tax scenario with a decreased SFA intake and a corresponding increase in PUFA. We compared this fat tax scenario to a reference scenario with no change in SFA intake, and to a guideline scenario with a population-wide SFA intake in line with dietary recommendations. We used DYNAMO-HIA to dynamically project the policy-attributable IHD cases of these three scenarios 10 years into the future. A fat tax would reduce prevalent IHD cases by a minimum of 500 and 300 among males and females in Denmark, respectively, up to a maximum of 5,600 and 4,000 among males and females in the UK. Thereby, the prevented IHD cases under a fat tax scenario would correspond to between 11.0% (in females in the Netherlands) and 29.5% (in females in Italy) of the prevented IHD cases under a guideline scenario, which represents the maximum preventable disease burden. Henceforth, our quantification of beneficial health impacts makes the case for the policy debate on fat taxes.

In 2018, 22 percent of girls aged 15 years of age in Portugal, and 31 percent of 15 year old boys in Greece were classed as overweight or obese, the highest share across all the European countries in this age group. Over the three age groups in Europe, there tends to be a higher share of overweight and obesity among boys.

Snapshot img

Fertility Supplements Market Size 2024-2028

The fertility supplements market size is forecast to increase by USD 761.7 million at a CAGR of 7.08% between 2023 and 2028.

The market is experiencing significant growth, driven by the increasing number of individuals turning to supplements to address fertility issues. This trend is particularly prominent In the US and other developed markets, where the availability of e-commerce has made these supplements more accessible. However, the market is not without challenges. One major concern is the potential risks associated with fertility supplements, particularly those containing unregulated ingredients. This has led to increased scrutiny from regulatory bodies and calls for greater transparency and standardization in the industry. Despite these challenges, opportunities abound for companies that can navigate this complex landscape. By focusing on research and development of safe and effective supplements, and implementing strong quality control measures, companies can differentiate themselves and capture market share. Additionally, partnerships with healthcare providers and insurers can help expand reach and drive adoption, making this an exciting space for innovation and growth.

What will be the Size of the Fertility Supplements Market during the forecast period?

Request Free Sample

The market has experienced significant growth in recent years, driven by various factors. Rising healthcare costs and changing lifestyles have led individuals to seek affordable alternatives to conventional fertility treatments. Medical advancements have expanded the knowledge of infertility causes, such as smoking, alcohol consumption, poor diet, mental stress, hormonal imbalances, age, weight gain, and other factors. These issues have become increasingly prevalent in today's society, contributing to the market's expansion. Alpha-amylase, selenium, zinc, and other essential vitamins and minerals are commonly found in fertility supplements, addressing various infertility concerns. The market encompasses both synthetic and natural ingredients, catering to diverse consumer preferences.
Regulations and product safety concerns have emerged as critical factors, shaping the market's direction. The obese population, smoking rates, alcohol use rates, and stress levels continue to influence the market's growth trajectory. Acquisitions and partnerships have also played a role In the market's consolidation, as companies seek to expand their offerings and reach larger audiences.

How is this Fertility Supplements Industry segmented?

The fertility supplements industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Women
  Men


Geography

  North America

    US


  Europe

    France
    Germany
    UK


  APAC

    China


  South America



  Middle East and Africa

By End-user Insights

The women segment is estimated to witness significant growth during the forecast period. Fertility supplements have gained significant attention In the healthcare market due to the increasing prevalence of infertility among women. Infertility affects approximately 20-30% of women of reproductive age, with factors including polycystic ovary syndrome (PCOS), endometriosis, and pelvic inflammatory disease impacting the female reproductive system. Lifestyle factors, such as poor diet, smoking, and alcohol consumption, also contribute to infertility. Medical advancements and changing lifestyles have led to an increase In the use of fertility supplements, which contain natural ingredients like Myo-Inositol, Selenium, Zinc, Folic acid, Vitamin C, Vitamin B6, CoQ1, and Vitamin E. These supplements aim to address hormonal imbalances, improve sperm shape, motility, and counts, and enhance semen ejection.

Get a glance at the market report of share of various segments Request Free Sample

The women segment was valued at USD 861.60 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market size of various regions, Request Free Sample

The North American market is experiencing growth due to increasing infertility rates and heightened public awareness of overall health. Infertility is on the rise, influenced by factors such as alcohol consumption, smoking, obesity, and stress, which disrupt the endocrine system and lead to hormonal imbalances, according to the World Health Organization (WHO). The US Department of Health and Human Serv

Snapshot img

Seaweed Market Size 2024-2028

The seaweed market size is projected to increase by USD 5.56 billion and is estimated to grow at a CAGR of 7.22% between 2023 and 2028. The market's growth is influenced by several factors, including enhanced marketing strategies, the rising demand for seaweed-flavored food and beverages, and growing health consciousness among consumers. Additionally, the increasing population base concerned about obesity is driving the market further. As consumers become more aware of the health benefits associated with seaweed, its popularity in food and beverage products is escalating. This trend is complemented by targeted marketing efforts that highlight seaweed's nutritional value and versatility in various culinary applications. Consequently, these factors collectively contribute to the expanding market for seaweed-flavored products, addressing the needs of a more health-conscious and informed consumer base.

Market Overview

The market shows an accelerated CAGR during the forecast period.

To get additional information about the market report, Request Free Sample

Market Dynamics and Customer Landscape

The market encompasses various types of macroalgae, including Blue, Brown, and Green seaweed. These seaweeds serve multiple purposes in diverse industries. In the Food and Beverages sector, they are used as Human food, Hydrocolloids, and Animal feed additives. The Agriculture industry utilizes seaweed as Fertilizers and Raw materials. In Aquaculture, seaweed is used for Animal feed and as a source of Macroalgae compounds for Immunity enhancement and Cancer treatment. Seaweed also finds applications in Personal care, Pharmaceuticals, and the Energy sector. Chlorophyll, a key compound in seaweed, is used in Biomedicine and as a Natural colorant. The Market for seaweed has shown robust Export performance, with Rocky shorelines serving as abundant sources. The demand for seaweed continues to grow due to its versatility and potential benefits in Food, Chemicals, and various Industries.

Key Market Driver

One of the key factors driving the market growth is the growing health consciousness and increasing obese population base. The market plays a pivotal role in various industries, including human food, hydrocolloids, fertilizers, animal feed additives, and aquaculture. Blue Growth initiative drives the demand for seaweed, with Red seaweed, Brown seaweed, and Green seaweed being the primary focus.

Moreover, seaweed is rich in chlorophyll, Beta carotene, and Xanthophylls, making it a valuable source for Carrageenan production. Health awareness has fueled the use of seaweed in food and beverages, animal feed, fertilizer, biofuel, personal care, fucoidan, pharmaceuticals, and agriculture. Seaweed manufacturers face volatility in prices due to weather patterns and raw material availability. Macroalgae compounds offer immunity enhancement and have potential applications in cancer treatment. Root structures and soil microbiology contribute to soil structure and water retention capacity. Iodine, Estradiol, and Estrogen are other essential elements found in seaweed, offering satiety and various health benefits. Hence, such factors are driving the market growth during the forecast period.

Significant Market Trends

A key factor shaping the market growth is the rising number of vegans and vegetarians. The market is experiencing significant growth due to the increasing adoption of seaweeds in the paleo diet. Seaweeds, which come in three colors - red, green, and brown - are rich in essential nutrients and are considered paleo food. Some common seaweeds used in paleo diets include dulse, which can be consumed as a snack or used to flavor foods. Seaweeds have various applications beyond human food. They are used as hydrocolloids in the food and beverages industry, as fertilizers and animal feed additives in agriculture, and as raw materials in the production of hydrocolloids, fertilizers, biofuels, and personal care products. Red seaweeds, such as dulse, are rich in chlorophyll, beta carotene, and xanthophylls, while brown seaweeds contain high levels of iodine, estradiol, and estrogen.

Green seaweeds are a source of carrageenan, a common hydrocolloid used in food and pharmaceutical industries. Seaweed manufacturers face volatility in prices due to weather patterns and the complex process of cultivating macroalgae compounds. However, the health benefits associated with seaweeds, including immunity enhancement and cancer treatment, make them a valuable resource for agriculture, food and beverages, animal feed, and pharmaceutical industries. Seaweed farming involves the cultivation of various species of macroalgae, which can improve soil microbiology, soil structure, and water retention capacity. Seaweeds are also used in the production of healthy foods, such as snacks and supplements, and have applications in the satiety market. Hence, such

Snapshot img

Nutrigenomics Market Forecast 2024-2028

The Global Nutrigenomics Market size is estimated to grow by USD 997.73 million at a CAGR of 13.87% between 2022 and 2027.

There have been growing investments by government and private stakeholders in field of nutrigenomics across the globe. Many private and government stakeholders are making higher investments in R&D activities to come up with innovative new technologies in the field of nutrigenomics as well as to boost the life sciences industry. For example, the NIH Common Fund Metabolomics Program supports the development of resources, such as data repositories, nutrigenomics tools, reference standards, and experimental protocols, which catalyze the effective use of nutrigenomics in both basic and translational biomedical research. Hence, such factors are positively impacting the market.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Application, Product, and Geography Analysis

The market leverages Buccal swabs and Saliva for Genomic data collection and analysis to drive Precision medicine and tailor Nutrition based on individual genetic profiles. This approach stems from groundbreaking initiatives like the Human Genome Project, aiding in understanding and addressing prevalent Cardiovascular illnesses, Cancer prevalence, and related Mortality rates. Athletes and health-conscious individuals benefit from Tailored nutrition plans designed by Sports dietitians and Nutritionists using insights from Gene sequencing methods and Nutritional genomics. This targeted approach reshapes Dietary choices and Nutrition habits, addressing Obesity and promoting overall Health through bioactive food components and optimized nutrient intake. The Sales of nutrigenomics tools and services facilitate better diagnostics and management of various Disease conditions, enhancing personalized well-being strategies and promoting healthier lifestyles.

Application Analysis

The obesity segment is estimated to witness significant growth during the forecast period. In recent times, the number of people who are obese has increased across the world. In addition, the bariatric patient population represents a growing segment across hospitals worldwide. Furthermore, obesity causes many diseases, such as osteoarthritis, gout, cardiac disease, and stroke, high blood pressure, diabetes, sleep apnea, kidney disease, fatty liver disease, pressure ulcers, gallbladder disease, and gallstones, and breathing problems.

Get a glance at the market contribution of various segments Download PDF Sample

The obesity segment was the largest segment and was valued at USD 292.79 million in 2018. Moreover, in nutrigenomics, nutrients are considered indicators that inform a specific cell in the body about the diet. In addition, the nutrients are detected by a sensor system in the cell, which works like sensory ecology wherein the cell obtains information through the signal, namely, the nutrient, about its environment. Furthermore, the sensory system interprets the information from nutrients regarding the dietary environment, including transcription factors, together with many additional proteins. In addition, once the nutrient interacts with the sensory system, it changes protein expression as well as gene and metabolite production in accordance with the level of nutrients that it senses. Hence, such factors are fuelling the growth of this segment which in turn drives the market during the forecast period.

Product Analysis

In the global market, reagent kits play a crucial role in allowing genetic testing and analysis for personalized nutrition interventions. In addition, these kits typically include DNA extraction reagents, genotyping assays, and other essential components for sample preparation and analysis. Moreover, DNA extraction reagents facilitate the isolation and purification of genetic material from various biological samples, such as saliva or blood, while genotyping assays allow for the detection of specific genetic variants associated with nutrient metabolism and health outcomes. Furthermore, reagent kits may also incorporate quality control measures to ensure the accuracy and reliability of test results. Hence, such factors are fuelling the growth of this segment which in turn drives the market during the forecast period.

In the global market, services are essential components in providing personalized nutrition solutions based on individual genetic profiles. In addition, these services encompass genetic testing, data analysis, and interpretation, providing insights into how genetic variations influence nutrient metabolism and dietary requirements. Moreover, genetic testing services involve sample collection, such as saliva or blood, followed by DNA analysis utilizing advanced sequencing or genotyping technologies. Furthermore, data analysis platforms t

Results of linear regression analysis with adjustment for age, sex and BMI are presented.a Risk allele reported in the previous reportsb values are log-transformed for the analysisBMI < 25; n = 428 for HOMA-IR and HOMA-β, n = 482 for FPGBMI ≥ 25; n = 374 for HOMA-IR and HOMA-β, n = 662 for FPGAssociation of rs8090011 in LAMA1 with quantitative traits related to glucose metabolism in obese controls (BMI ≥ 25) or in non-obese controls (BMI < 25).